TV-based assistive integrated service to support European adults living with mild dementia or mild cognitive impairment (TV-AssistDem): study protocol for a multicentre randomized controlled trial

Jessica Marian Goodman-Casanova, José Guzmán-Parra, Gloria Guerrero, Elisa Vera, Pilar Barnestein-Fonseca, Gabriella Cortellessa, Francesca Fracasso, Alessandro Umbrico, Amedeo Cesta, Diana Toma, Flavia Boghiu, Rodolphe Dewarrat, Valentina Triantafyllidou, Elena Tamburini, Pietro Dionisio, Fermín Mayoral, Jessica Marian Goodman-Casanova, José Guzmán-Parra, Gloria Guerrero, Elisa Vera, Pilar Barnestein-Fonseca, Gabriella Cortellessa, Francesca Fracasso, Alessandro Umbrico, Amedeo Cesta, Diana Toma, Flavia Boghiu, Rodolphe Dewarrat, Valentina Triantafyllidou, Elena Tamburini, Pietro Dionisio, Fermín Mayoral

Abstract

Background: Mild cognitive impairment and mild dementia progressively compromise the ability of people to live independently and can have a negative impact on their quality of life. Within the current European Active and Assisted Living programme (AAL), project TV-AssistDem has been developed to deliver a TV-based platform service to support patients with mild cognitive impairment or mild dementia and provide relief to their caregivers. The application is intended to be used daily at home, mainly by the participants themselves, with the help of their informal caregivers. The aim of this study is to evaluate the effectiveness of TV-AssistDem to improve quality of life in people with mild cognitive impairment or mild dementia.

Methods: This is a 12-month European multicentre randomized controlled trial which will be performed in two countries: Spain and Romania. Two hundred and forty older adults will be recruited using identical inclusion/exclusion criteria. The primary outcome will be the change from baseline of TV-AssistDem on patient quality of life at 12 months. The secondary outcomes will be the changes from baseline of: 1) informal caregiver quality of life, 2) informal caregiver burden, 3) patient treatment adherence, 4) patient treatment compliance, 5) patient functional status, and 6) healthcare cost-effectiveness at 12 months. Patients in the intervention group will have access to an interactive platform which offers remote assistive services through a device connected to the television. The core services of the platform are: 1) Calendar and reminders, 2) Health monitoring and data transmission to a health server and 3) Videoconference; service-oriented applications are: 4) Cognitive stimulation; 5) Reminiscences; and 6) Patient and caregiver healthcare education. The analysis will be made following an intention-to-treat procedure. Linear and Generalized Mixed Model analysis will be performed.

Discussion: We hypothesize that the regular use of TV-AssistDem will result in an improvement in patient quality of life. The uniqueness of this home TV-based intervention lies on its widespread accessibility and its integrative approach to quality of life in people with mild cognitive impairment or mild dementia and their informal caregivers. However, several anticipated challenges will need to be faced: poor engagement and connectivity problems.

Trial registration: ClinicalTrials.gov Identifier NCT03653234 , Date of registration: 31 August 2018.

Keywords: Ambient assisted living; Assistive technology; Dementia; Informal caregivers; Person with dementia; Quality of life; Remote consultations; Telemedicine.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
TV-AssistDem system
Fig. 2
Fig. 2
Main menu functionalities

References

    1. World Health Organization and Alzheimer’s Disease. Dementia: a public health priority. 2012.
    1. Calleo J, Stanley M. Anxiety disorders in later life. Psychiatr Times. 2008;25:24.
    1. Panegyres PK, Berry R, Burchell J. Early Dementia Screening. Diagnostics (Basel, Switzerland) [Internet]. 21 de enero de 2016 [citado 25 de julio de 2018];6(1). Disponible en: .
    1. International Alzheimer’s Disease. The Global Impact of Dementia An analysis of prevalence, incidence, cost and trends. 2015.
    1. Bleijlevens MHC, Stolt M, Stephan A, Zabalegui A, Saks K, Sutcliffe C, et al. Changes in caregiver burden and health-related quality of life of informal caregivers of older people with dementia: evidence from the European RightTimePlaceCare prospective cohort study. J Adv Nurs. 2015;71(6):1378–1391. doi: 10.1111/jan.12561.
    1. Johansson MM, Marcusson J, Wressle E. Cognitive impairment and its consequences in everyday life: experiences of people with mild cognitive impairment or mild dementia and their relatives. Int Psychogeriatrics junio de. 2015;27(06):949–958. doi: 10.1017/S1041610215000058.
    1. Fisher GG, Franks MM, Plassman BL, Brown SL, Potter GG, Llewellyn D, et al. Caring for individuals with dementia and CIND: findings from the aging, demographics, and memory study. J Am Geriatr Soc. 2011;59(3):488–494. doi: 10.1111/j.1532-5415.2010.03304.x.
    1. Winblad B, Cedazo-Minguez A, Graff C, Johansson G, Jönsson L, Kivipelto M, et al. The lancet neurology commission defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(15):455–532. doi: 10.1016/S1474-4422(16)00062-4.
    1. Cooper C, Mukadam N, Katona C, Lyketsos CG, Ames D, Rabins P, et al. Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. Int Psychogeriatr junio de. 2012;24(6):856–870. doi: 10.1017/S1041610211002614.
    1. Kuyken W, Orley J, Power M, Herrman H, Schofield H, Murphy B, et al. The World Health Organization quality of life assessment (WHOQOL) - position paper from the World Health Organization. Soc Sci Med noviembre de. 1995;41(10):1403–1409. doi: 10.1016/0277-9536(95)00112-K.
    1. Khosravi P, Ghapanchi AH. Investigating the effectiveness of technologies applied to assist seniors: a systematic literature review. Int J Med Inform junio de. 2016;85(1):17–26. doi: 10.1016/j.ijmedinf.2015.05.014.
    1. Chinner A, Blane J, Lancaster C, Hinds C, Koychev I. Digital technologies for the assessment of cognition: a clinical review. Evid Based Ment Health [Internet]. 1 de mayo de 2018 [citado 25 de junio de 2018];21(2):67–71. Disponible en: .
    1. World Health Organization. ADHERENCE TO LONG-TERM THERAPIES: EVIDENCE FOR ACTION. WHO. World Health Organization; 2015.
    1. Arlt S, Lindner R, Rösler A, von Renteln-Kruse W. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging. 2008.
    1. Hudani ZK, Rojas-Fernandez CH. A scoping review on medication adherence in older patients with cognitive impairment or dementia. Res Soc Adm Pharm noviembre de. 2016;12(6):815–829. doi: 10.1016/j.sapharm.2015.11.011.
    1. Smith D, Janaka L, Weller C, Kennedy B, Winbolt M, Young C, et al. A systematic review of medication non- adherence in persons with dementia or cognitive impairment. PLoS One. 2017;12(2):e0170651. doi: 10.1371/journal.pone.0170651.
    1. NICE-SCIE. Dementia - Supporting people with dementia and their carers in health and social care. En London; 2006.
    1. Orrell M, Yates LA, Burns A, Russell I, Woods RT, Hoare Z, et al. Individual Cognitive Stimulation Therapy for dementia (iCST): study protocol for a randomized controlled trial. Trials. diciembre de 2012;13(1):172.
    1. Thorgrimsen L, Selwood A, Spector A, Royan L, de Madariaga LM, Woods RT, et al. Whose quality of life is it anyway? Alzheimer Dis Assoc Disord. 2003;17(4):201–208. doi: 10.1097/00002093-200310000-00002.
    1. Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med mayo de. 2002;64(3):510–519. doi: 10.1097/00006842-200205000-00016.
    1. Logsdon RG, Gibbons LE, McCurry SM, Teri L. Quality of life in Alzheimer’s disease: patient and caregiver reports. J Ment Heal Aging. 1999;5(1):21–32.
    1. Gómez-Gallego M, Gómez-Amor J, Gómez-García J. Validación de la versión española de la escala QoL-AD en pacientes con enfermedad de Alzheimer, cuidadores y profesionales sanitarios. Neurologia. 2012;27(1):4–10. doi: 10.1016/j.nrl.2011.03.006.
    1. Devlin NJ, Krabbe PFM. The development of new research methods for the valuation of EQ-5D-5L. Eur J Health Econ. 2013;14(SUPPL. 1):1–3. doi: 10.1007/s10198-013-0502-3.
    1. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res diciembre de. 2011;20(10):1727–1736. doi: 10.1007/s11136-011-9903-x.
    1. Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist diciembre de. 1980;20(6):649–655. doi: 10.1093/geront/20.6.649.
    1. Bedard M, Molloy DW, Squire L, Dubois S, Lever JA, O’Donnell M. The Zarit burden interview: a new short version and screening version. Gerontologist. 2001;41(5):652–657. doi: 10.1093/geront/41.5.652.
    1. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2(6):757–764. doi: 10.1161/01.HYP.2.6.757.
    1. Sackett DavidL., Gibson EdwardS., Wayne Taylor D., Brian Haynes R., Hackett BrendaC., Roberts RobinS., Johnson ArnoldL. RANDOMISED CLINICAL TRIAL OF STRATEGIES FOR IMPROVING MEDICATION COMPLIANCE IN PRIMARY HYPERTENSION. The Lancet. 1975;305(7918):1205–1207. doi: 10.1016/S0140-6736(75)92192-3.
    1. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother marzo de. 2009;43(3):413–422. doi: 10.1345/aph.1L496.
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care enero de. 1986;24(1):67–74. doi: 10.1097/00005650-198601000-00007.
    1. Val Jiménez A, Amorós Ballestero G, Martínez Visa P, Fernández Ferré ML, León Sanromà M. [Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test]. Aten primaria. octubre de 1992;10(5):767–770.
    1. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist enero de. 1969;9(3):179–186. doi: 10.1093/geront/9.3_Part_1.179.
    1. Chisholm D, Knapp MR, Knudsen HC, Amaddeo F, Gaite L, van Wijngaarden B. Client Socio-Demographic and Service Receipt Inventory-European Version: development of an instrument for international research. EPSILON Study 5. European Psychiatric Services: inputs Linked to Outcome Domains and Needs. Br J Psychiatry Suppl. 2000;39:28–63. doi: 10.1192/bjp.177.39.s28.
    1. Beecham J, Knapp M. 12 Costing psychiatric interventions. En: G. Thornicroft, editor. Measuring Mental Health Needs. 2a. 2001. p. 200–24.
    1. Tsoi Kelvin K.F., Chan Joyce Y.C., Hirai Hoyee W., Wong Adrian, Mok Vincent C.T., Lam Linda C.W., Kwok Timothy C.Y., Wong Samuel Y.S. Recall Tests Are Effective to Detect Mild Cognitive Impairment: A Systematic Review and Meta-analysis of 108 Diagnostic Studies. Journal of the American Medical Directors Association. 2017;18(9):807.e17-807.e29. doi: 10.1016/j.jamda.2017.05.016.
    1. Aguado C, Martínez J OM. Adaptación y validación al castellano de la versión abreviada de la “Geriatric Depresión Scale” (GDS) de Yesavage. Aten primaria / Soc Española Med Fam y Comunitaria. 2000;26 (supl 1:328.
    1. Brooke J. SUS : a retrospective. J Usability Stud. 2013;8(2):29–40.
    1. Bangor A, Kortum P, Miller J. Determining what individual SUS scores mean: adding an adjective rating scale. J Usability Stud. 2009;4(3):114–123.
    1. Stimulus [Internet]. citado 4 de julio de 2018. 2018.
    1. Goeman D, Comans T, Enticott JC, Renehan E, Beattie E, Kurrle S, et al. Evaluating the Efficacy of the “Support for Life” Program for People with Dementia and Their Families and Carers’ to Enable Them to Live Well: A Protocol for a Cluster Stepped Wedge Randomized Controlled Trial. Front Public Heal. 2016;4(November):245.
    1. Woods RT, Orrell M, Bruce E, Edwards RT, Hoare Z, Hounsome B, et al. REMCARE: pragmatic multi-Centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PLoS One. 2016;11(4):1–19. doi: 10.1371/journal.pone.0152843.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere